Where can I find PRLD's financial statements?

Prelude Therapeutics Incorporated (PRLD)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for PRLD?

Prelude Therapeutics Incorporated (PRLD) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does PRLD update its statements?

Prelude Therapeutics Incorporated files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

PRLD

Prelude Therapeutics Incorporated

NASDAQ·Biotechnology · Healthcare

$6.56$0.03−0.46%

After hours·$6.71+2.29%

Market cap$373.48M·Market closed·Aug 26 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$0.00	$0.00	$0.00	$7.00M	$12.14M+73.4%
Cost of revenue	—	—	—	—	$1.71M
Gross profit	$0.00	$0.00	$0.00	$7.00M	$10.43M+49.0%
Research & development	$86.78M+80.1%	$92.89M+7.0%	$103.39M+11.3%	$118.00M+14.1%	$94.30M−20.1%
General & administrative	$26.96M+154.6%	$30.65M+13.7%	$28.88M−5.8%	$28.72M−0.6%	$22.41M−22.0%
SG&A (combined)	$26.96M+154.6%	$30.65M+13.7%	$28.88M−5.8%	$28.72M−0.6%	$22.41M−22.0%
Other operating expenses	—	—	−$1.00	—	−$1.71M
Total operating expenses	$113.74M+93.5%	$123.54M+8.6%	$132.28M+7.1%	$146.71M+10.9%	$115.00M−21.6%
Operating income	−$113.74M−93.5%	−$123.54M−8.6%	−$132.28M−7.1%	−$139.71M−5.6%	−$104.57M+25.2%
Other income / (expense), net	$2.04M+11.3%	$8.10M+297.0%	$10.44M+28.9%	$12.54M+20.1%	$5.07M−59.6%
Income before tax	−$111.69M−96.2%	−$115.44M−3.4%	−$121.83M−5.5%	−$127.17M−4.4%	−$99.50M+21.8%
Net income	−$111.69M−96.2%	−$115.44M−3.4%	−$121.83M−5.5%	−$127.17M−4.4%	−$99.50M+21.8%

EPS (basic)	−$2.33−79.2%	−$2.27+2.6%	−$2.02+11.0%	−$1.68+16.8%	−$1.29+23.2%
EPS (diluted)	−$2.33−79.2%	−$2.27+2.6%	−$2.02+11.0%	−$1.68+16.8%	−$1.29+23.2%
Weighted avg shares (basic)	47,602,336	47,371,589	60,357,000	75,805,840	76,956,194
Weighted avg shares (diluted)	47,602,336	47,371,589	60,357,052	75,805,840	76,956,194

Depreciation & amortization	$915.00K+68.8%	$1.32M+44.7%	$1.17M−11.7%	$1.77M+51.6%	$1.71M−3.4%
EBITDA	−$110.78M−90.3%	−$114.11M−3.0%	−$120.66M−5.7%	−$125.40M−3.9%	−$97.79M+22.0%

Frequently Asked Questions About PRLD

Where can I find PRLD's financial statements?: Prelude Therapeutics Incorporated (PRLD)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for PRLD?: Prelude Therapeutics Incorporated (PRLD) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does PRLD update its statements?: Prelude Therapeutics Incorporated files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.